LACE+ and MRS Score Readmission Rate Assessment

Terminated

• Conditions: Hospitalism
• Interventions: Other: Pharmacist transition of care consultation

• Registration Number: NCT04365673
• Lead Sponsor: Tabula Rasa HealthCare

Brief Summary

A study to demonstrate that the LACE+ score in non-inferior to the medication risk score when predicting 30-day readmission post hospital discharge.

Detailed Description

The objective of this study is evaluate a program that provides transition of care services to a local Tucson hospital involving activities designed to reduce 30 day post hospital discharge readmission rates. The organization has had a fee for service contract with this hospital since 2017 to provide pharmacist delivered transition of care services. The organization collects internal tracking outcome data as part of the contract deliverable and is required to report it to the hospital once per month. The investigators look to assess LACE+ and medication risk scores to learn if there is an association with the 30 day post hospital discharge readmission rate post pharmacist intervention. The outcomes will not be generalizable and will be reported back to the hospital client to demonstrate value added.

Study Timeline

• Study First Submitted: 2020-04-24
• Study First Submitted QC: 2020-04-24
• Study First Posted: 2020-04-28
• Study Start: 2020-07-07
• Primary Completion: 2021-03-01
• Study Completion: 2021-03-01
• Status Verified: 2022-03
• Last Update Submitted: 2022-03-02
• Last Update Posted: 2022-03-17

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Those referred to receive transition of care services between January 2018 to December 2019 and were discharged on 10 or more medications.

Exclusion Criteria

• 89 years or older

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Readmitted	Pharmacist transition of care consultation	Patients that were readmitted within 30 days post hospital discharge
Not readmitted	Pharmacist transition of care consultation	Patients that were not readmitted within 30 days post hospital discharge

Primary Outcome Measures

Name	Time	Method
Readmission	2018 - 2019	Readmission within 30-days post hospital discharge

Trial Locations

Locations (1)

Tabula Rasa HealthCare; 🇺🇸 Tucson, Arizona, United States